4.5 Article

Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Public, Environmental & Occupational Health

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines

Kathleen L. Dooling et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)

Article Medicine, General & Internal

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

A. L. Cunningham et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, General & Internal

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

Himal Lal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Editorial Material Clinical Neurology

THE GLOBAL EPIDEMIOLOGY OF HERPES ZOSTER

Barbara P. Yawn et al.

NEUROLOGY (2013)

Article Medicine, General & Internal

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

MN Oxman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)